Diaceutics has released a strong trading update, including a 15pp increase in the proportion of sales coming from the DXRX platform, to 75%: this is hugely positive for earnings & cash flow visibility as platform revenue tends to be multi-year and recurring in nature.
Revenue was +25% organically and the order book reached £10m, becoming material for the first time. Management is delivering on its goal to contract more multi-year, predictable revenue streams. We expect further material growth ....
26 Jul 2022
Diaceutics - Trading Update - July 22
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Diaceutics - Trading Update - July 22
Diaceutics Plc (DXRX:LON) | 103 0 0.0% | Mkt Cap: 87.2m
- Published:
26 Jul 2022 -
Author:
Oliver Juggins -
Pages:
7
Diaceutics has released a strong trading update, including a 15pp increase in the proportion of sales coming from the DXRX platform, to 75%: this is hugely positive for earnings & cash flow visibility as platform revenue tends to be multi-year and recurring in nature.
Revenue was +25% organically and the order book reached £10m, becoming material for the first time. Management is delivering on its goal to contract more multi-year, predictable revenue streams. We expect further material growth ....